Drug Type Small molecule drug |
Synonyms Furegrelate sodium (USAN), Furegrelic acid, U 63557A + [1] |
Target |
Action inhibitors |
Mechanism TXA2 synthase inhibitors(Thromboxane A2 synthase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H11NO3 |
InChIKeyVHWFITPGPFLBGT-UHFFFAOYSA-N |
CAS Registry85666-24-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04276 | Furegrelate | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arrhythmias, Cardiac | Phase 2 | United States | - | |
Arrhythmias, Cardiac | Phase 2 | - | - | |
Myocardial Ischemia | Phase 2 | United States | - | |
Myocardial Ischemia | Phase 2 | - | - | |
Thrombosis | Phase 2 | United States | - | |
Thrombosis | Phase 2 | - | - |